AIRS Medical said on October 5, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for SwiftSight Body Composition, its AI-powered quantitative MRI software, with SimonMed Imaging as the first customer to deploy it. The Chicago-datelined announcement said the clearance expands the company’s quantitative MRI platform into body composition analysis. SwiftSight Body Composition uses AI-powered MRI analysis to quantify muscle and adipose tissue from MR images. According to…